NCT07216131View on ClinicalTrials.gov

A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

November 10, 2025

Primary Completion Date

December 29, 2025

Study Completion Date

December 29, 2025

Conditions

Healthy Participants

Interventions

DRUG

AZD0780

AZD0780 will be administered orally.

DRUG

Metformin

Metformin will be administered orally.

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY